Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer
2022 · Cancer Cell International · 72 citations
https://doi.org/10.1186/s12935-022-02815-4
M
Mohammed Moustapha Anwar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
435
Citations
9
h-index
9
i10-index
Mohammed Moustapha Anwar is an academic researcher from Centro de Investigacion Principe Felipe. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Migration, Health and Trauma & Microbial Metabolism and Applications. The author has an h-index of 9, co-authored 12 publications.
ORCID: 0000-0001-5035-8463Papers by this author
worksProdigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights
2020 · Scientific Reports · 62 citations
https://doi.org/10.1038/s41598-020-71157-w
Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies
2023 · Current Oncology Reports · 34 citations
https://doi.org/10.1007/s11912-023-01408-2
Monkeypox and human transmission: Are we on the verge of another pandemic?
2022 · Travel Medicine and Infectious Disease · 28 citations
https://doi.org/10.1016/j.tmaid.2022.102387
Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection
2022 · Inflammation · 6 citations
https://doi.org/10.1007/s10753-022-01674-5
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM)
2023 · Journal of the Egyptian Public Health Association · 4 citations
https://doi.org/10.1186/s42506-022-00125-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat